Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$50.47 - $66.26 $3.13 Million - $4.11 Million
-62,085 Closed
0 $0
Q3 2020

Nov 04, 2020

SELL
$51.97 - $63.0 $618,443 - $749,700
-11,900 Reduced 16.08%
62,085 $3.73 Million
Q2 2020

Jul 31, 2020

SELL
$30.8 - $52.47 $197,120 - $335,808
-6,400 Reduced 7.96%
73,985 $3.88 Million
Q1 2020

May 08, 2020

SELL
$28.4 - $50.7 $193,120 - $344,760
-6,800 Reduced 7.8%
80,385 $2.7 Million
Q4 2019

Feb 11, 2020

SELL
$36.31 - $46.83 $755,248 - $974,064
-20,800 Reduced 19.26%
87,185 $3.95 Million
Q3 2019

Nov 01, 2019

BUY
$35.66 - $44.99 $360,165 - $454,399
10,100 Added 10.32%
107,985 $4.11 Million
Q2 2019

Aug 13, 2019

BUY
$36.57 - $47.97 $1.98 Million - $2.59 Million
54,088 Added 123.5%
97,885 $4.26 Million
Q1 2019

May 15, 2019

SELL
$36.47 - $42.17 $679 Million - $785 Million
-18,624,000 Reduced 99.77%
43,797 $1.67 Million
Q1 2019

May 13, 2019

BUY
$36.47 - $42.17 $679 Million - $786 Million
18,631,200 Added 50909.09%
18,667,797 $20 Million
Q4 2018

Feb 14, 2019

SELL
$41.31 - $52.16 $2.36 Million - $2.98 Million
-57,203 Reduced 60.98%
36,597 $1.57 Million
Q3 2018

Nov 14, 2018

SELL
$32.85 - $52.0 $811,395 - $1.28 Million
-24,700 Reduced 20.84%
93,800 $4.61 Million
Q2 2018

Aug 06, 2018

BUY
$27.5 - $39.8 $2.97 Million - $4.3 Million
108,000 Added 1028.57%
118,500 $3.8 Million
Q1 2018

May 03, 2018

BUY
$29.98 - $46.35 $314,790 - $486,675
10,500 New
10,500 $327,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.2B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.